Calif. Judge Won't Halt Sale Of Prenatal Blood Test In IP Row

Law360, New York (July 6, 2012, 6:44 PM EDT) -- A federal judge on Thursday allowed Ariosa Diagnostics Inc. to continue selling its noninvasive prenatal Harmony test, dismissing competitor Sequenom Inc.’s motion for a preliminary injunction claiming the product infringes on its patent for a competing test.

Ariosa began marketing the test in March, after suing Sequenom in federal court in California in December for declaratory relief stating it did not infringe on its rival’s patent. Sequenon, which markets the MaterniT21 prenatal test, then moved for a preliminary injunction, seeking to prevent Ariosa from making and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.